These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21560181)

  • 41. Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.
    Wollmann G; Ozduman K; van den Pol AN
    Cancer J; 2012; 18(1):69-81. PubMed ID: 22290260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncology's Trojan Horse: Using Viruses to Battle Cancer.
    Mavani HJ; Wick JY
    Consult Pharm; 2016 Dec; 31(12):676-684. PubMed ID: 28074746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncolytic vaccinia virus: from bedside to benchtop and back.
    Thorne SH
    Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measles to the Rescue: A Review of Oncolytic Measles Virus.
    Aref S; Bailey K; Fielding A
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The pros and cons of interferons for oncolytic virotherapy.
    Geoffroy K; Bourgeois-Daigneault MC
    Cytokine Growth Factor Rev; 2020 Dec; 56():49-58. PubMed ID: 32694051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. United virus: the oncolytic tag-team against cancer!
    Le Boeuf F; Bell JC
    Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current status of clinical trials assessing oncolytic virus therapy for urological cancers.
    Taguchi S; Fukuhara H; Homma Y; Todo T
    Int J Urol; 2017 May; 24(5):342-351. PubMed ID: 28326624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of oncolytic virotherapy: from genetic modification to combination therapy.
    Lan Q; Xia S; Wang Q; Xu W; Huang H; Jiang S; Lu L
    Front Med; 2020 Apr; 14(2):160-184. PubMed ID: 32146606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncorine, the World First Oncolytic Virus Medicine and its Update in China.
    Liang M
    Curr Cancer Drug Targets; 2018; 18(2):171-176. PubMed ID: 29189159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncolytic virus therapy using genetically engineered herpes simplex viruses.
    Todo T
    Front Biosci; 2008 Jan; 13():2060-4. PubMed ID: 17981691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncolytic viruses: what to expect from their use in cancer treatment.
    Terrível M; Gromicho C; Matos AM
    Microbiol Immunol; 2020 Jul; 64(7):477-492. PubMed ID: 31663631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent progress in the battle between oncolytic viruses and tumours.
    Parato KA; Senger D; Forsyth PA; Bell JC
    Nat Rev Cancer; 2005 Dec; 5(12):965-76. PubMed ID: 16294217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncolytic virotherapy.
    Russell SJ; Peng KW; Bell JC
    Nat Biotechnol; 2012 Jul; 30(7):658-70. PubMed ID: 22781695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy.
    Allan KJ; Mahoney DJ; Baird SD; Lefebvre CA; Stojdl DF
    J Vis Exp; 2018 Apr; (134):. PubMed ID: 29683442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterizing Cellular Responses During Oncolytic Maraba Virus Infection.
    Hassanzadeh G; Naing T; Graber T; Jafarnejad SM; Stojdl DF; Alain T; Holcik M
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30700020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncolytic herpes simplex virus and immunotherapy.
    Ma W; He H; Wang H
    BMC Immunol; 2018 Dec; 19(1):40. PubMed ID: 30563466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virus, Oncolytic Virus and Human Prostate Cancer.
    Liu GB; Zhao L; Zhang L; Zhao KN
    Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.